Untargeted metabolomics reveals transformation pathways and metabolic response of the earthworm Perionyx excavatus after exposure to triphenyl phosphate.
Lei WangXulei HuangAnna Karen Carrasco LasernaSam Fong-Yau LiPublished in: Scientific reports (2018)
Triphenyl phosphate (TPHP) is one of the most highly utilized organophosphorus flame retardants, and has been frequently detected in various environmental matrices, including soil. So far, limited information is known regarding the potential toxicity of TPHP to the earthworm-soil ecosystem. We investigated the metabolism of TPHP and the perturbation of the endogenous metabolome in the earthworm, Perionyx excavatus, using gas chromatography mass spectrometry (GC-MS) and liquid chromatography quadrupole time-of-flight (LC-QTOF)-based untargeted metabolomics approach after acute exposure to TPHP for one and two days through a filter paper contact test, as well as after chronic exposure for 28 days in a soil microcosm experiment. TPHP showed low bioaccumulation potential in the earthworm-soil ecosystem at concentrations of 10 mg/kg and 50 mg/kg. Identified phase I metabolites include diphenyl phosphate, mono-hydroxylated and di-hydroxylated TPHP. Two groups of phase II metabolites, thiol conjugates (including mercaptolactic acid, cysteine, cysteinylglycine, and mercaptoethanol conjugates) and glucoside conjugates (including glucoside, glucoside-phosphate, and C14H19O10P conjugates), were putatively identified. Only acute TPHP exposure caused significant perturbations of the endogenous metabolome in earthworms, featuring fluctuations in amino acids, glucose, inosine and phospholipids. These results reveal novel phase II metabolism and toxicity of TPHP in P. excavatus.
Keyphrases
- mass spectrometry
- phase ii
- liquid chromatography
- gas chromatography mass spectrometry
- human health
- clinical trial
- gas chromatography
- high resolution mass spectrometry
- open label
- ms ms
- tandem mass spectrometry
- solid phase extraction
- risk assessment
- simultaneous determination
- high performance liquid chromatography
- cancer therapy
- phase iii
- placebo controlled
- gene expression
- amino acid
- liver failure
- randomized controlled trial
- single cell
- high resolution
- type diabetes
- cystic fibrosis
- social media
- adipose tissue
- blood glucose
- genome wide
- skeletal muscle
- fatty acid
- drinking water